1. Home
  2. BOTJ vs EQ Comparison

BOTJ vs EQ Comparison

Compare BOTJ & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of the James Financial Group Inc.

BOTJ

Bank of the James Financial Group Inc.

HOLD

Current Price

$17.80

Market Cap

71.6M

Sector

Finance

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$0.85

Market Cap

57.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOTJ
EQ
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
57.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BOTJ
EQ
Price
$17.80
$0.85
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
4.0K
433.6K
Earning Date
10-30-2025
11-13-2025
Dividend Yield
2.25%
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$47,669,000.00
$4,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.22
N/A
Revenue Growth
8.53
N/A
52 Week Low
$11.56
$0.27
52 Week High
$18.50
$2.35

Technical Indicators

Market Signals
Indicator
BOTJ
EQ
Relative Strength Index (RSI) 60.66 35.50
Support Level $17.50 $0.81
Resistance Level $18.04 $0.92
Average True Range (ATR) 0.62 0.10
MACD -0.00 0.00
Stochastic Oscillator 65.09 10.98

Price Performance

Historical Comparison
BOTJ
EQ

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: